Antibiotic resistance · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
Antibiotics for trachoma 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Adverse effects · people (any age) with active trachoma
1 finding from 1 review
Active trachoma · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
Antibiotics for trachoma 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Vaginal delivery not achieved within 24 hours · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine hyperstimulation with fetal heart rate changes · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious maternal morbidity or death · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant global assessment VAS Visual analogue scale (VAS) (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Pain VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Nodules score Nodule count · participants with hidradenitis suppurativa
1 finding from 1 review
Abscesses score Abscess count · participants with hidradenitis suppurativa
1 finding from 1 review
Physician global assessment VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Clinical failure clinical observation · patients with BCG adverse reactions1
It is very uncertain whether oral erythromycin changes clinical failure clinical observation compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Patient assessed efficacy ‐ pain · patients with pain associated with endometriosis
1 finding from 1 review
Objective efficacy at end of · patients with pain associated with endometriosis
1 finding from 1 review
Adverse effects: headache · patients with pain associated with endometriosis
Oral progestagens probably leads to lower side effects ‐ headache compared with other treatment (moderate certainty).
1 finding from 1 review
Side effects ‐ hot flushes · patients with pain associated with endometriosis
Oral progestagens may leads to lower side effects ‐ hot flushes compared with other treatment (low certainty).
1 finding from 1 review
Side effects ‐ genital bleeding · patients with pain associated with endometriosis
Oral progestagens may leads to higher side effects ‐ genital bleeding compared with other treatment (low certainty).
1 finding from 1 review
Side effects ‐ amenorrhoea · patients with pain associated with endometriosis
It is very uncertain whether oral progestagens changes side effects ‐ amenorrhoea compared with other treatment (very low certainty).
1 finding from 1 review